- Home
- GSHD vs NBTX Comparison
GSHD vs NBTX Comparison
Compare GSHD & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GSHD | NBTX |
|---|---|---|
| Founded | 2003 | 2003 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | GSHD | NBTX |
|---|---|---|
| Price | $40.68 | $45.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 1 |
| Target Price | ★ $72.50 | $36.00 |
| AVG Volume (30 Days) | ★ 381.2K | 56.8K |
| Earning Date | 04-22-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.04 | N/A |
| Revenue | ★ $365,304,000.00 | N/A |
| Revenue This Year | $16.40 | $58.17 |
| Revenue Next Year | $18.53 | N/A |
| P/E Ratio | $40.72 | ★ N/A |
| Revenue Growth | ★ 16.15 | N/A |
| 52 Week Low | $39.64 | $3.64 |
| 52 Week High | $114.76 | $44.46 |
Technical Indicators
Market Signals| Indicator | GSHD | NBTX |
|---|---|---|
| Relative Strength Index (RSI) | 39.34 | 72.20 |
| Support Level | N/A | $20.11 |
| Resistance Level | $46.40 | N/A |
| Average True Range (ATR) | 2.86 | 2.08 |
| MACD | -0.51 | 1.20 |
| Stochastic Oscillator | 3.26 | 99.80 |
Price Performance
Historical ComparisonAbout GSHD Goosehead Insurance Inc.
Goosehead Insurance Inc operates as an insurance agency. Its insurance products consist of homeowner's insurance; auto insurance; other personal lines products including flood, wind and earthquake insurance; excess liability or umbrella insurance; specialty lines insurance (motorcycle, recreational vehicle and other insurance); commercial lines insurance (general liability, property, and auto insurance for small businesses); and life insurance. Geographically, it operates in Texas, California, Illinois, Florida, and other regions. The company is has a single reportable segment: insurance distribution.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.